Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Oxford Square reported on Monday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Oxford Square announced earnings per share of $0.110 on revenue of $11.4M. Analysts polled by Investing.com EPS of $0.110 on revenue of $11.3M.
Oxford Square 's are down 57% and is trading at $3.098 , still down 30.69% from its 52 week high of $4.47 set on Friday, November 12, 2021.
Oxford Square shares gained 2.91% to trade at $3.098 in intra-day trade the report.
Oxford Square follows other major Financial sector earnings this month
Oxford Square's report follows an earnings missed by Berkshire Hathaway A on Saturday, who reported EPS of $-1,832 on revenue of $76.9B, EPS of $4,518.39 on revenue of $74.9B.
JPMorgan had beat expectations on Friday, October 14, 2022 with third quarter EPS of $3.12 on revenue of $32.72B, for EPS of $2.92 on revenue of $32.13B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar